跳至主要内容
临床试验/JPRN-UMIN000008165
JPRN-UMIN000008165招募中2 期

Randomized phase II trial of adjuvant chemotherapy with vinorelbine plus cisplatin versus S-1 plus carboplatin in patients with completely resected stage II/IIIA non-small cell lung cancer - Adjuvant VNR+CDDP vs CBDCA+S-1 for Stage II/IIIA NSCLC

Fukushima medical University Hospital0 个研究点目标入组 60 人开始时间: 2012年6月13日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Contraindication with S-1, carboplatin, vinorelbine and cisplatin 2) With large cell neuroendocrine carcinoma(LCNEC) 3) With interstitial pneumonitis or pulmonary fibrosis detectable on chest X-ray 4) With double cancer, multiple cancer 5) With Serious post-operative complications 6) With severe drug allergies 7) With serious concurrent disease 8) With serious diarrhea 9) Current use of flucytosine 10) Lactating, pregnant or possibly pregnant women, or those willing to become pregnant 11) Physician concludes that the patient's participation in this trial is inappropriate

研究者

相似试验